PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportssquamous cell neoplasms
MeSH D018307 - squamous cell neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009375:Glandular and epithelial neoplasms
0 Companies
0 Drugs
Success rate
D018307: 
Squamous cell neoplasms
$
Success rate
D002291:Papillary carcinoma
0 Companies
0 Drugs
Success rate
D002294:Squamous cell carcinoma
$
Success rate
D010212:Papilloma
0 Companies
0 Drugs
Success rate
D018289:Verrucous carcinoma
0 Companies
0 Drugs
Success rate
D049309:Acanthoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Regeneron PharmaceuticalsCemiplimab Libtayo  2019-06-28 $1,093.7 M Q4/23-Q3/24 
Clinical Trials
Historical Success Rate
Phase 1
74%
55/74
Phase 2
25%
28/110
Phase 3
17%
7/41
Approved: 0Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Biolitec Pharma
Regeneron Pharmaceuticals
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use